Get started
NEUROCRINE BIOSCIENCES INCNEUROCRINE BIOSCIENCES INCNEUROCRINE BIOSCIENCES INC

NEUROCRINE BIOSCIENCES INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Forecast

1NBIX chart


Full chart

1NBIX upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪9.61 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
32.48
Basic EPS (TTM)
3.28 EUR
Net income (FY)
‪329.69 M‬ EUR
Revenue (FY)
‪2.28 B‬ EUR
Shares float
‪96.08 M‬
Beta (1Y)
0.65

Employees


Employees (FY)
‪1.8 K‬
Change (1Y)
+400 +28.57%
Revenue / Employee (1Y)
‪1.26 M‬ EUR
Net income / Employee (1Y)
‪183.16 K‬ EUR

About Neurocrine Biosciences, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Kyle W. Gano
Website
neurocrine.com
Headquarters
San Diego
Founded
1992
FIGI
BBG01TNX42H0
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

1NBIX news



Ideas



See all ideas 

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Sparks


Curated watchlists where 1NBIX is featured.

See all sparks 


Check out other big names from the same industry as 1NBIX.

Frequently Asked Questions


The current price of 1NBIX is 96.00 EUR — it has increased by 1.37% in the past 24 hours. Watch NEUROCRINE BIOSCIENCES INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange NEUROCRINE BIOSCIENCES INC stocks are traded under the ticker 1NBIX.
1NBIX stock has risen by 1.12% compared to the previous week, the month change is a 1.12% rise, over the last year NEUROCRINE BIOSCIENCES INC has showed a 1.12% increase.
We've gathered analysts' opinions on NEUROCRINE BIOSCIENCES INC future price: according to them, 1NBIX price has a max estimate of 170.10 EUR and a min estimate of 85.05 EUR. Watch 1NBIX chart and read a more detailed NEUROCRINE BIOSCIENCES INC stock forecast: see what analysts think of NEUROCRINE BIOSCIENCES INC and suggest that you do with its stocks.
1NBIX reached its all-time high on May 2, 2025 with the price of 96.00 EUR, and its all-time low was 92.16 EUR and was reached on Apr 25, 2025. View more price dynamics on 1NBIX chart.
See other stocks reaching their highest and lowest prices.
1NBIX stock is 1.35% volatile and has beta coefficient of 0.65. Track NEUROCRINE BIOSCIENCES INC stock price on the chart and check out the list of the most volatile stocks — is NEUROCRINE BIOSCIENCES INC there?
Yes, you can track NEUROCRINE BIOSCIENCES INC financials in yearly and quarterly reports right on TradingView.
NEUROCRINE BIOSCIENCES INC is going to release the next earnings report on May 5, 2025. Keep track of upcoming events with our Earnings Calendar.
1NBIX earnings for the last quarter are 0.97 EUR per share, whereas the estimation was 1.55 EUR resulting in a −37.72% surprise. The estimated earnings for the next quarter are 0.49 EUR per share. See more details about NEUROCRINE BIOSCIENCES INC earnings.
NEUROCRINE BIOSCIENCES INC revenue for the last quarter amounts to ‪606.34 M‬ EUR, despite the estimated figure of ‪608.04 M‬ EUR. In the next quarter, revenue is expected to reach ‪517.29 M‬ EUR.
1NBIX net income for the last quarter is ‪99.59 M‬ EUR, while the quarter before that showed ‪116.58 M‬ EUR of net income which accounts for −14.57% change. Track more NEUROCRINE BIOSCIENCES INC financial stats to get the full picture.
No, 1NBIX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 4, 2025, the company has ‪1.8 K‬ employees. See our rating of the largest employees — is NEUROCRINE BIOSCIENCES INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NEUROCRINE BIOSCIENCES INC EBITDA is ‪589.34 M‬ EUR, and current EBITDA margin is 26.50%. See more stats in NEUROCRINE BIOSCIENCES INC financial statements.
Like other stocks, 1NBIX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NEUROCRINE BIOSCIENCES INC stock right from TradingView charts — choose your broker and connect to your account.